FPR2 and Alzheimer disease: Formylpeptide receptor 2 (FPR2) and ROS-responsive p38 mitogen-activated protein kinase (MAPK) have also been implicated in this phenotypic senescence modification in the hippocampus (He et al., 2013), which may be associated with neurogenesis failure and related memory decline in AD.